Rituxan (rituximab) - Roche
Rethinking Common Diagnoses: Idiopathic Multicentric Castleman Disease Presenting as TAFRO Syndrome: A Case Report. (PubMed, Clin Case Rep) - Oct 3, 2026 - "As fine-needle aspiration is often non-diagnostic, early excisional biopsy is important. Rituximab-based therapy represents a guideline-supported alternative when anti-IL-6 treatment is unavailable or not feasible." 
Journal • Rare Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42824722
 
Annesha Chakraborty; Anurag Rohatgi; Divita Rohatgi; Sourav Kumar
 
Oct 3, 2026
 
Prev Next